Consolidated statements of shareholders' equity - USD ($) $ in Thousands	Common stock	Additional paid-in capital	Accumulated other comprehensive (loss) income	Retained deficit	Total
Common stock, par value (in dollars per share)					$ 0.01
Balance at the beginning of period at Mar. 30, 2019	$ 481	$ 863,978	$ (26,132)	$ (573,634)	$ 264,693
Balance (in shares) at Mar. 30, 2019	48,142,319
Increase (Decrease) in Stockholders' Equity
Net loss				(4,099)	(4,099)
Stock-based compensation		811			811
Vesting of restricted stock awards	$ 2	(56)			(54)
Vesting of restricted stock awards (in shares)	140,878
Taxes related to net share settlement of restricted stock awards		(347)			(347)
Foreign currency translation adjustment			333		333
Unrealized gain on financial instruments, net of tax provision			(128)		(128)
Pension liability adjustment, net of $0			(2)		(2)
Balance at the end of period at Jun. 29, 2019	$ 483	864,386	(25,929)	(577,733)	$ 261,207
Balance (in shares) at Jun. 29, 2019	48,283,197
Common stock, par value (in dollars per share)					$ 0.01
Common stock, par value (in dollars per share)					$ 0.01
Balance at the beginning of period at Mar. 28, 2020	$ 483	866,667	(36,295)	(559,147)	$ 271,708
Balance (in shares) at Mar. 28, 2020	48,316,559
Increase (Decrease) in Stockholders' Equity
Net loss				(16,670)	(16,670)
Stock-based compensation		832			832
Vesting of restricted stock awards	$ 2	(2)			0
Vesting of restricted stock awards (in shares)	174,810
Taxes related to net share settlement of restricted stock awards		(165)			(165)
Foreign currency translation adjustment			3,583		3,583
Unrealized gain on financial instruments, net of tax provision			3,961		3,961
Pension liability adjustment, net of $0			(219)		(219)
Balance at the end of period at Jun. 27, 2020	$ 485	$ 867,332	$ (28,970)	$ (575,817)	$ 263,030
Balance (in shares) at Jun. 27, 2020	48,491,369
Common stock, par value (in dollars per share)					$ 0.01